Medicamen Organics Limited — Board Meeting, 29-05-2025: Outcome of Board Meeting

Medicamen Organics has announced a board meeting where it approved the audited standalone and consolidated financial results for the half year and full year ended March 31, 2025. The auditors gave a clean opinion, confirming strong financial health. The board also reviewed the use of IPO proceeds and allotment of 4,65,910 fully convertible warrants issued in March 2025. No dividend or other significant operational updates were announced. The company continues to demonstrate transparency in fund utilization alongside solid audited results.